0
The FDA has released a request for comments soliciting public input on new opportunities and emergent monitoring needs for possible inclusion in the forthcoming National Antimicrobial Resistance Monitoring System (NARMS) 2026-2030 Strategic Plan.
NARMS is a collaborative program of state and local public health departments and universities, the FDA, the Centers for Disease Control and Prevention (CDC), and the U.S. Department of Agriculture (USDA). This national public health surveillance system tracks changes in the antimicrobial susceptibility of enteric (intestinal) bacteria found in ill people, retail meats, and food animals in the United States.
The comment period opens on January 10 and will be open until March 28. Relevant public comments submitted to docket FDA-2024-N-5538 will help inform the development of a draft 2026-2030 NARMS Strategic Plan. NARMS intends to hold a public meeting in the spring of 2025 to share an outline of the draft strategic plan for discussion.
January 8, 2025/ FDA/ United States.
https://www.fda.gov/
